A Multi-center, Longitudinal, Observational Study of Children With Achondroplasia

CompletedOBSERVATIONAL
Enrollment

260

Participants

Timeline

Start Date

June 19, 2019

Primary Completion Date

January 12, 2024

Study Completion Date

January 12, 2024

Conditions
Achondroplasia
Trial Locations (35)

1

Ascendis Pharma Investigational Site, Dublin

1005

Ascendis Pharma Investigational Site, Lausanne

1008

Ascendis Pharma Investigational Site, Vitoria-Gasteiz

1142

Ascendis Pharma Investigational Site, Auckland

2100

Ascendis Pharma Investigational Site, Copenhagen

3000

Ascendis Pharma Investigational Site, Coimbra

3052

Ascendis Pharma Investigational Site, Parkville

4020

Ascendis Pharma Investigational Site, Linz

8950

Ascendis Pharma Investigational Site, Esplugues de Llobregat

13353

Ascendis Pharma Investigational Site, Berlin

14203

Ascendis Pharma Investigational Site, Buffalo

19803

Ascendis Pharma Investigational Site, Wilmington

20082

Ascendis Pharma Investigational Site, Shanghai

20132

Ascendis Pharma Investigational Site, Milan

28046

Ascendis Pharma Investigational Site, Madrid

53705

Ascendis Pharma Investigational Site, Madison

55102

Ascendis Pharma Investigational Site, Saint Paul

65212

Ascendis Pharma Investigational Site, Columbia

72211

Ascendis Pharma Investigational Site, Little Rock

75743

Ascendis Pharma Investigational Site, Paris

77030

Ascendis Pharma Investigational Site, Houston

80045

Ascendis Pharma Investigational Site, Aurora

94609

Ascendis Pharma Investigational Site, Oakland

98105

Ascendis Pharma Investigational Site, Seattle

100045

Ascendis Pharma Investigational Site, Beijing

310053

Ascendis Pharma Investigational Site, Hangzhou

430030

Ascendis Pharma Investigational Site, Wuhan

510080

Ascendis Pharma Investigational Site, Guangzhou

518053

Ascendis Pharma Investigational Site, Shenzhen

T6G-1C9

Ascendis Pharma Investigational Site, Edmonton

51H 8L1

Ascendis Pharma Investigational Site, Ottawa

H3T 1C5

Ascendis Pharma Investigational Site, Montreal

08035

Ascendis Pharma Investigational Site, Barcelona

G51 4TF

Ascendis Pharma Investigational Site, Glasgow

SE1 7EU

Ascendis Pharma Investigational Site, London

Sponsors
All Listed Sponsors
lead

Ascendis Pharma A/S

INDUSTRY